Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country–Nepal: Cost, Efficacy, and Safety

Intravenous alteplase is the only approved treatment for acute ischemic stroke. Tenecteplase, a genetically engineered, mutant tissue plasminogen activator, is an alternative thrombolytic agent. The economic feasibility of stroke treatment has been a matter of huge debate and discussion thus far. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nepal, Gaurav, Kharel, Ghanshyam, Ahamad, Shaik Tanveer, Basnet, Babin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890961/
https://www.ncbi.nlm.nih.gov/pubmed/29651371
http://dx.doi.org/10.7759/cureus.2178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890961/
https://www.ncbi.nlm.nih.gov/pubmed/29651371
http://dx.doi.org/10.7759/cureus.2178

Ejemplares similares